# FDA Warning Letter: Fagron Group B.V.
> 2022-06-28 · Division of Pharmaceutical Quality Operations III · `503bc3c1256bbe56`
## Letter
- **Company:** Fagron Group B.V.
- **Posted Date:** 2022-06-28
- **Letter Issue Date:** 2022-06-14
- **Issuing Office:** Division of Pharmaceutical Quality Operations III
## Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*